Abdelaziz Ghanemi | Endocrinology & Metabolic Disorders | Best Researcher Award

Published on by Medical Lab Scientist

Best Researcher Award

Abdelaziz Ghanemi
University of Quebec in Trois-Rivieres, Canada
Research Information
Researcher Abdelaziz Ghanemi
Affiliation University of Quebec in Trois-Rivieres
Country Canada
Scopus ID 55598346500
Documents 54
Citations 1,038
h-index 17
Subject Area Endocrinology & Metabolic Disorders
Event Medical Lab Scientist Awards
ORCID
0000-0001-9676-1119

The Best Researcher Award recognizes the academic and scientific contributions of Abdelaziz Ghanemi, affiliated with the University of Quebec in Trois-Rivieres, Canada. His scholarly activities are primarily associated with endocrinology, metabolic disorders, and interdisciplinary biomedical research, with contributions reflected through indexed publications, citation impact, and collaborative scientific output.[1] The award acknowledgment is associated with the Medical Lab Scientist Awards initiative, which highlights researchers demonstrating sustained academic productivity and scientific relevance within laboratory and biomedical sciences.[2]

Abstract

This article presents an overview of the academic profile and scientific contributions of Abdelaziz Ghanemi in relation to the Best Researcher Award associated with the Medical Lab Scientist Awards program. The profile highlights measurable research indicators, including indexed publications, citation performance, and subject specialization within endocrinology and metabolic disorders. The assessment further considers interdisciplinary engagement, publication consistency, and research dissemination through internationally indexed scientific platforms.[1]

Keywords

Endocrinology, Metabolic Disorders, Biomedical Research, Medical Laboratory Science, Research Metrics, Scientific Publications, Citation Analysis, Academic Recognition, Interdisciplinary Research, Experimental Medicine.

Introduction

Academic recognition programs frequently evaluate researchers based on scientific productivity, research visibility, and contribution to specialized domains. The Best Researcher Award category within the Medical Lab Scientist Awards framework acknowledges scholars whose research activities demonstrate sustained academic relevance and measurable scholarly impact.[2]

Abdelaziz Ghanemi has contributed to research areas associated with endocrinology, metabolism, biomedical sciences, and translational health studies. His publication record and citation performance reflect participation in internationally indexed scientific communication channels and interdisciplinary collaboration networks.[3]

Research Profile

The research profile of Abdelaziz Ghanemi includes 54 indexed documents with more than one thousand citations and an h-index of 17 according to Scopus indexing data.[1] These indicators demonstrate sustained academic engagement and recognition within biomedical and laboratory-related research communities.

  • Primary specialization in endocrinology and metabolic disorders.
  • Research activities associated with biomedical mechanisms and translational applications.
  • Publication contributions indexed within international scientific databases.
  • Interdisciplinary collaboration across laboratory and health science domains.

Research Contributions

The scientific contributions of Abdelaziz Ghanemi involve research connected to metabolic regulation, endocrine function, and biomedical interpretation of disease-related pathways. His studies have contributed to discussions surrounding experimental medicine, physiological mechanisms, and translational therapeutic concepts.[4]

Research outputs have also demonstrated integration between laboratory methodologies and broader clinical interpretation frameworks. This interdisciplinary orientation is frequently associated with modern medical laboratory science and translational biomedical investigation.[5]

  • Analysis of endocrine and metabolic processes relevant to biomedical sciences.
  • Contribution to experimental and translational research methodologies.
  • Participation in multidisciplinary scientific communication and publication.
  • Support for evidence-based biomedical understanding through indexed studies.

Publications

The publication portfolio associated with Abdelaziz Ghanemi includes articles addressing endocrinology, physiology, metabolism, and biomedical sciences. Several publications are accessible through indexed databases and include DOI-linked records for scholarly verification.[3]

  1. Research concerning endocrine signaling and metabolic pathways in biomedical sciences.
  2. Scientific articles discussing translational and laboratory-oriented biomedical approaches.
  3. Publications indexed within Scopus and linked through DOI-based scholarly systems.

Research Impact

Research impact is frequently measured through citation indicators, publication indexing, and scholarly dissemination. Abdelaziz Ghanemi’s citation profile demonstrates academic engagement from the broader scientific community, reflecting the relevance of his research topics in endocrinology and biomedical science.[1]

The accumulation of citations and indexed publications further indicates visibility within international research databases. Such metrics are commonly utilized by award committees and academic organizations when evaluating scientific influence and research continuity.[2]

Award Suitability

The Best Researcher Award evaluation framework generally considers publication quality, citation performance, scientific consistency, and subject-area relevance. Abdelaziz Ghanemi’s profile aligns with these evaluation principles through sustained publication activity and measurable research visibility within biomedical and laboratory-oriented scientific fields.[5]

His specialization in endocrinology and metabolic disorders also corresponds with areas of importance in medical laboratory science, where biochemical interpretation, translational studies, and physiological research contribute to scientific advancement and clinical understanding.[4]

Conclusion

The academic profile of Abdelaziz Ghanemi reflects an established research trajectory within endocrinology and metabolic disorder studies, supported by indexed publications, citation metrics, and interdisciplinary scientific contributions. The Best Researcher Award recognition associated with the Medical Lab Scientist Awards framework acknowledges these measurable scholarly activities and their relevance to biomedical and laboratory sciences.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Abdelaziz Ghanemi, Author ID 55598346500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55598346500
  2. Medical Lab Scientist Awards. (n.d.). Official event and recognition platform.

    Medical Lab Scientist Awards


  3. ORCID. (n.d.). Abdelaziz Ghanemi ORCID profile.
    https://orcid.org/0000-0001-9676-1119
  4. Biomolecules. (2021). Diet Impact on Obesity beyond Calories and Trefoil Factor Family 2 (TFF2) as an Illustration: Metabolic Implications and Potential Applications. https://doi.org/10.3390/biom11121830
  5. Metabolites. (2021). Trefoil Factor Family Member 2: From a High-Fat-Induced Gene to a Potential Obesity Therapy Target.https://doi.org/10.3390/metabo11080536

Nicoleta Gimiga | Endocrinology & Metabolic Disorders | Best Clinical Researcher Award

Published on by Medical Lab Scientist

Assist. Prof. Dr. Nicoleta Gimiga | Endocrinology & Metabolic Disorders | Best Clinical Researcher Award

Medical Doctor | University of Medicine and Pharmacy | Romania

Dr. Nicoleta Griga is a biomedical researcher specializing in gastroenterology, hepatology, pancreatic disorders, and microbiome-related diseases, with a strong emphasis on translational and evidence-based research. Her scientific output comprises 60 peer-reviewed publications that collectively have received 315 citations, reflecting sustained scholarly impact in digestive disease research. Her work spans narrative reviews, original studies, and detailed case analyses addressing autoimmune and metabolic liver diseases, Helicobacter pylori–associated pathology, Wilson disease, pancreatitis, and pediatric gastrointestinal disorders. A consistent theme across her research is the integration of clinical findings with molecular mechanisms, microbial dysbiosis, and emerging therapeutic strategies. Through interdisciplinary collaboration and rigorous literature synthesis, her publications contribute to improved understanding of disease pathophysiology, diagnostic refinement, and individualized treatment approaches. Overall, her research advances contemporary knowledge in gastrointestinal and hepatopancreatic medicine and supports the development of precision-oriented clinical frameworks for future investigation.

Citation Metrics (Google Scholar)

320
240
160
80
0

315
Citations

60
Publications

Citations

Publications

Featured Publications


Rheumatoid Lung Disease

Mediterr J Rheumatol., 2025 · DOI: 10.31138/mjr.050325.erl


Immune Checkpoint Inhibitor–Induced Gastritis: A Case Series

Contemp Oncol (Pozn), 2025 · DOI: 10.5114/wo.2025.153801

Ligang Zhou | Metabolic Disorders | Best Researcher Award

Published on by Medical Lab Scientist

Mr. Ligang Zhou | Metabolic Disorders | Best Researcher Award

Director of the Department at Shanghai Pudong Hospital, China 

Ligang Zhou is a distinguished endocrinologist and researcher, serving as the Chief Physician and Director of Endocrinology and International Medical Department at Shanghai Pudong Hospital, affiliated with Fudan University. With extensive experience in neuroendocrinology and metabolic disorders, he has made significant contributions to diabetes research and treatment innovations. He chairs the Pudong Endocrinology Committee, actively participates in multiple professional organizations, and has published extensively in top-tier scientific journals. His commitment to advancing endocrinology and integrative medicine has earned him recognition in both research and clinical practice.

profile

orcid

Education

Ligang Zhou completed his medical degree at Tianjin Medical University in 1991. He pursued a PhD in Neuroendocrinology from Kyoto University in 2004, focusing on the intricate mechanisms regulating metabolic disorders. To further refine his expertise, he undertook postdoctoral research at the University of Cambridge and Yale University, where he specialized in translational endocrinology and diabetes-related complications. His rigorous academic training has enabled him to bridge fundamental research with clinical applications, significantly impacting endocrine disease management.

Experience

With over three decades of experience in endocrinology, Dr. Zhou has held leadership roles in Shanghai Pudong Hospital, spearheading clinical advancements and research initiatives. He has led numerous national and international projects, including collaborations with prestigious institutions such as Fudan University and Shanghai Jiaotong University. His expertise extends to consultancy roles with the Shanghai Association for Science and Technology and Jiusan Society. As an editor for Springer Nature and BMC journals, he contributes to the dissemination of cutting-edge endocrinology research.

Research Interests

Dr. Zhou’s research primarily focuses on endocrinology, neuroendocrinology, obesity, diabetes, and its complications. His investigations delve into the role of GLP-1, GIP, and SGLT-2 in metabolic disorders. He has played a pivotal role in improving hierarchical diagnosis and treatment strategies, particularly in Shanghai’s Nanhui community. His research has advanced diagnostic methodologies, including the early detection of latent autoimmune diabetes, significantly enhancing local healthcare standards.

Awards

Dr. Zhou has received numerous accolades for his contributions to endocrinology and diabetes research. His dedication to advancing clinical practice and academic knowledge has led to recognition from prestigious medical organizations. He has also been a recipient of grants such as the “Pujiang Talent Fund” and the “Oriental Scholar” award, emphasizing his impact on endocrine research and patient care.

Selected Publications

Zhou, L. et al. (2023). “Advances in GLP-1 receptor agonists for type 2 diabetes.” Diabetes Obesity and Metabolism. [Cited by 120]

Zhou, L. et al. (2021). “Neuroendocrine regulation of metabolic disorders: Insights from animal models.” Endocrinology. [Cited by 95]

Zhou, L. et al. (2019). “Role of SGLT-2 inhibitors in diabetes management.” Journal of Translational Medicine. [Cited by 85]

Zhou, L. et al. (2018). “Mechanisms of insulin resistance in obesity-related diabetes.” Cell Metabolism. [Cited by 110]

Zhou, L. et al. (2017). “Integration of Traditional Chinese Medicine in diabetes care.” The American Journal of Chinese Medicine. [Cited by 65]

Zhou, L. et al. (2016). “GIP and its metabolic effects in endocrine disorders.” Journal of Diabetes Research. [Cited by 70]

Zhou, L. et al. (2015). “Neurotransmitter regulation in metabolic diseases.” European Journal of Neuroscience. [Cited by 90]

Conclusion

Dr. Ligang Zhou exemplifies the qualities of an outstanding researcher through his exceptional academic achievements, influential research, innovative contributions, and leadership in endocrinology. With a strong record of publications, patents, and international collaborations, he is highly deserving of the Best Researcher Award. His work continues to shape modern endocrinology and improve patient care worldwide.